TABLE OF CONTENTS
1 INTRODUCTION 10
1.1 OBJECTIVES OF THE STUDY 10
1.2 MARKET DEFINITION 10
1.3 OVERVIEW OF INDONESIA CORPORATE TELEHEALTH MARKET 10
1.4 LIMITATION 11
1.5 MARKETS COVERED 12
2 MARKET SEGMENTATION 15
2.1 MARKETS COVERED 15
2.2 GEOGRAPHICAL SCOPE 16
2.3 YEARS CONSIDERED FOR THE STUDY 16
2.4 CURRENCY AND PRICING 16
2.5 DBMR TRIPOD DATA VALIDATION MODEL 17
2.6 COMPONENT LIFE LINE CURVE 20
2.7 MULTIVARIATE MODELING 21
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 22
2.9 DBMR MARKET POSITION GRID 24
2.10 MARKET END-USER COVERAGE GRID 25
2.11 DBMR MARKET CHALLENGE MATRIX 26
2.12 SECONDARY SOURCES 27
2.13 ASSUMPTIONS 28
3 EXECUTIVE SUMMARY 29
4 PREMIUM INSIGHTS 31
4.1 MARKET STRATEGIC INITIATIVES 32
4.2 PESTLE ANALYSIS 33
4.2.1 POLITICAL FACTORS 33
4.2.2 ECONOMIC FACTORS 33
4.2.3 SOCIAL FACTORS 34
4.2.4 TECHNOLOGICAL FACTORS 34
4.2.5 LEGAL FACTORS 34
4.2.6 ENVIRONMENTAL FACTORS 34
4.3 PORTERS FIVE FORCES: 35
4.3.1 THREAT OF NEW ENTRANTS: 35
4.3.2 THREAT OF SUBSTITUTES: 35
4.3.3 CUSTOMER BARGAINING POWER: 36
4.3.4 SUPPLIER BARGAINING POWER: 36
4.3.5 INTERNAL COMPETITION (RIVALRY): 36
4.4 TECHNOLOGICAL ANALYSIS 37
4.5 VALUE CHAIN ANALYSIS 38
5 MARKET OVERVIEW 40
5.1 DRIVERS 42
5.1.1 INCREASE IN EFFORTS TO EMPLOY BETTER HEALTHCARE SERVICES QUALITY 42
5.1.2 GROWING PREVALENCE OF CHRONIC DISEASES AND CONDITIONS 43
5.1.3 SHORTAGE OF PHYSICIANS AND MEDICAL STAFF AS PER THE INDONESIAN POPULATION 43
5.2 RESTRAINTS 44
5.2.1 RISKS ASSOCIATED WITH CYBER-SECURITY THREATS AND SECURING DATA PROTECTIONS 44
5.2.2 INCREASING INSTANCES OF HEALTHCARE FRAUDS 45
5.3 OPPORTUNITIES 45
5.3.1 RISING ' 'GOVERNMENT'S MEASURES TO DEPLOY PROGRAMS WITH LEADING TELEHEALTH PLATFORMS 45
5.3.2 SHIFTING CONSUMER PREFERENCE TOWARD TELEHEALTH SERVICES 46
5.4 CHALLENGE 47
5.4.1 TECHNICAL PROBLEMS RELATED TO MEDICAL PROCEDURES 47
6 INDONESIA CORPORATE TELEHEALTH MARKET, BY COMPONENT 48
6.1 OVERVIEW 49
6.1.1 SERVICES 50
6.1.1.1 MANAGED SERVICES 50
6.1.1.2 PROFESSIONAL SERVICES 50
6.1.1.3 TRAINING AND CONSULTING 50
6.1.1.4 IMPLEMENTATION AND INTEGRATION 50
6.1.1.5 SUPPORT AND MAINTENANCE 50
6.1.2 SOFTWARE 51
6.1.2.1 REAL-TIME INTERACTIONS 51
6.1.2.2 REMOTE PATIENT MONITORING 51
6.1.2.3 STORE-AND-FORWARD CONSULTATIONS 51
6.1.2.4 OTHERS 51
6.1.3 HARDWARE 51
6.1.3.1 MONITORS 52
6.1.3.2 MEDICAL PERIPHERAL DEVICES 52
6.1.3.3 BLOOD PRESSURE MONITORS 52
6.1.3.4 BLOOD GLUCOSE METERS 52
6.1.3.5 PULSE OXIMETERS 52
6.1.3.6 WEIGHT SCALES 52
6.1.3.7 PEAK FLOW METERS 53
6.1.3.8 ECG MONITORS 53
6.1.3.9 ACCESSORIES 53
6.1.3.10 OTHERS 53
7 INDONESIA CORPORATE TELEHEALTH MARKET, BY DELIVERY MODEL 54
7.1 OVERVIEW 55
7.1.1 CLOUD 56
7.1.2 ON-PREMISE 56
8 INDONESIA CORPORATE TELEHEALTH MARKET, BY APPLICATION 57
8.1 OVERVIEW 58
8.1.1 VIRTUAL PRIMARY CARE AND CONTINUING CARE 59
8.1.1.1 DIABETIC SOLUTIONS 59
8.1.1.1.1 DIABETIC 59
8.1.1.1.2 PRE-DIABETIC 59
8.1.1.2 WEIGHT MANAGEMENT 60
8.1.1.3 OUTPATIENT CARE SOLUTIONS 60
8.1.1.4 HEART DISEASE 60
8.1.1.5 ASTHMA 60
8.1.2 TELERADIOLOGY 60
8.1.3 COMPREHENSIVE BEHAVIORAL HEALTH/TELEPSYCHIATRY 60
8.1.4 DERMATOLOGY CARE 60
8.1.4.1 HIGH-ACUITY CARE 60
8.1.4.1.1 STROKE SOLUTIONS 61
8.1.4.1.2 ICU 61
8.1.5 PEDIATRIC CORPORATE TELEHEALTH 61
8.1.6 OTHERS 61
9 INDONESIA CORPORATE TELEHEALTH MARKET, BY CONNECTIVITY DEVICE 62
9.1 OVERVIEW 63
9.1.1 SMART PHONE 64
9.1.2 LAPTOP 64
9.1.3 OTHERS 64
10 INDONESIA CORPORATE TELEHEALTH MARKET, BY END-USER 65
10.1 OVERVIEW 66
10.2 HEALTHCARE PROVIDERS 67
10.3 HOSPITALS 67
10.4 CLINICS 67
10.5 DIAGNOSTIC CENTERS 67
10.6 PHARMACIES 67
10.7 AMBULATORY SURGERY CENTERS (ASCS) 67
10.8 OTHERS 68
10.9 PATIENTS 68
10.10 HEALTHCARE PAYERS 68
10.11 PRIVATE 68
10.12 ICU 68
11 INDONESIA CORPORATE TELEHEALTH MARKET, COMPANY LANDSCAPE 69
11.1 COMPANY SHARE ANALYSIS: INDONESIA 69
11.1.1 CERTIFICATIONS 69
11.1.2 FUNDING 70
11.1.3 ACHIEVEMENT 70
11.1.4 COLLOBORATION 70
12 SWOT ANALYSIS 71
13 COMPANY PROFILES 72
13.1 HALODOC 72
13.1.1 COMPANY SNAPSHOT 72
13.1.2 PRODUCT PORTFOLIO 72
13.1.3 RECENT UPDATES 73
13.2 ALODOKTER 74
13.2.1 COMPANY SNAPSHOT 74
13.2.2 PRODUCT PORTFOLIO 74
13.2.3 RECENT UPDATES 74
13.3 PROSEHAT 75
13.3.1 COMPANY SNAPSHOT 75
13.3.2 PRODUCT PORTFOLIO 75
13.3.3 RECENT UPDATES 75
13.4 GOOD DOCTOR 76
13.4.1 COMPANY SNAPSHOT 76
13.4.2 PRODUCT PORTFOLIO 76
13.4.3 RECENT UPDATE 77
13.5 AIDO HEALTH 78
13.5.1 COMPANY SNAPSHOT 78
13.5.2 PRODUCT PORTFOLIO 78
13.5.3 RECENT UPDATE 78
13.6 PT MEDIKA KOMUNIKA TEKNOLOGI 79
13.6.1 COMPANY SNAPSHOT 79
13.6.2 PRODUCT PORTFOLIO 79
13.6.3 RECENT UPDATES 79
13.7 VASCULAR INDONESIA 80
13.7.1 COMPANY SNAPSHOT 80
13.7.2 PRODUCT PORTFOLIO 80
13.7.3 RECENT UPDATES 80
13.8 CISCO SYSTEMS, INC. 81
13.8.1 COMPANY SNAPSHOT 81
13.8.2 REVENUE ANALYSIS 81
13.8.3 PRODUCT PORTFOLIO 82
13.8.4 RECENT UPDATE 83
13.9 GET HEALTHY INDONESIA 84
13.9.1 COMPANY SNAPSHOT 84
13.9.2 PRODUCT PORTFOLIO 84
13.9.3 RECENT UPDATES 84
13.10 HEALTHY LINK 85
13.10.1 COMPANY SNAPSHOT 85
13.10.2 PRODUCT PORTFOLIO 85
13.10.3 RECENT UPDATES 85
13.11 INTEL CORPORATION 86
13.11.1 COMPANY SNAPSHOT 86
13.11.2 REVENUE ANALYSIS 86
13.11.3 PRODUCT PORTFOLIO 87
13.11.4 RECENT UPDATES 87
13.12 TRUSTMEDIS INDONESIA 88
13.12.1 COMPANY SNAPSHOT 88
13.12.2 PRODUCT PORTFOLIO 88
13.12.3 RECENT UPDATES 88
14 QUESTIONNAIRE 89
15 RELATED REPORTS 92

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.